A coagulation profile is a group of blood tests that shows how well, and how quickly, your blood forms a clot. In clinical practice it is used to investigate unexplained bleeding or bruising, check clotting before surgery, monitor blood thinners such as warfarin and heparin, and assess serious illnesses like liver disease or sepsis that disturb clotting. The core tests are the prothrombin time (PT) with its INR, the activated partial thromboplastin time (aPTT), fibrinogen and, often, a platelet count.
In haematology I order coagulation profiles almost every day. Below I explain what each test measures, what normal values look like, how to read common abnormal patterns, and where the profile has limits.
What Does a Coagulation Profile Measure?
Stopping bleeding, or hemostasis, happens in two overlapping stages. First, platelets stick to the injured vessel and form a loose plug. Second, a chain of clotting proteins called coagulation factors activate one another and convert fibrinogen into strands of fibrin, which knit the plug into a stable clot. I cover this sequence in detail in my article on the coagulation process.
Laboratory tests divide the cascade into the intrinsic and extrinsic pathways, which meet at a common pathway. This model is simplified compared with what happens in the body, but it is very useful for interpreting results, because each test is sensitive to a different set of factors.
The Core Tests and Normal Ranges
Reference ranges vary between laboratories and depend on the reagents used, so always compare a result with the range printed on the report. The values below are typical textbook ranges for adults.
| Test | What it reflects | Typical adult range |
|---|---|---|
| Prothrombin time (PT) | Extrinsic and common pathways (factors VII, X, V, II, fibrinogen) | About 11 to 13.5 seconds |
| INR | Standardized PT, used mainly to monitor warfarin | About 0.8 to 1.1 (usual warfarin target 2.0 to 3.0) |
| Activated partial thromboplastin time (aPTT) | Intrinsic and common pathways (factors XII, XI, IX, VIII, X, V, II, fibrinogen) | About 25 to 35 seconds |
| Fibrinogen | Amount of the protein that becomes fibrin | About 200 to 400 mg/dL (2 to 4 g/L) |
| Thrombin time (TT) | Conversion of fibrinogen to fibrin | Roughly 14 to 19 seconds |
| Platelet count | Number of platelets available for the first plug | 150,000 to 450,000 per microliter |
A D-dimer test is sometimes added. D-dimer is a breakdown product of fibrin, so a normal result helps rule out a blood clot in low-risk patients, while a raised result is non-specific and needs context.
When Is a Coagulation Profile Ordered?
Bleeding symptoms
Easy bruising, frequent or prolonged nosebleeds, heavy menstrual periods, bleeding gums, or bleeding that continues long after a small cut or dental extraction all justify testing. Bleeding into joints or muscles suggests a clotting factor problem such as hemophilia. My overview of the different types of bleeding disorders explains how these patterns differ.
Before surgery or procedures
A profile is often checked before major surgery, liver biopsy or line insertion, especially if the patient has a bleeding history, liver disease or takes anticoagulants. A careful bleeding history is at least as important as the tests themselves.
Monitoring anticoagulants
The INR guides warfarin dosing, and the aPTT has traditionally been used to monitor unfractionated heparin. Newer direct oral anticoagulants do not need routine monitoring, but they can affect the PT and aPTT, which matters when interpreting results.
Serious illness
Liver failure, severe infection, major trauma and obstetric emergencies can all derange clotting. In these settings the profile helps detect disseminated intravascular coagulation (DIC) and guides transfusion of plasma, cryoprecipitate or platelets.
Interpreting Abnormal Patterns
No single result makes a diagnosis. I look at the pattern across tests alongside the history and examination.
- Prolonged PT/INR, normal aPTT: warfarin therapy, vitamin K deficiency, early liver disease or, rarely, factor VII deficiency.
- Prolonged aPTT, normal PT: heparin, hemophilia A or B (factor VIII or IX deficiency), factor XI deficiency, some cases of von Willebrand disease, or a lupus anticoagulant. Factor XII deficiency also prolongs the aPTT but does not cause bleeding.
- Both PT and aPTT prolonged: advanced liver disease, DIC, severe vitamin K deficiency, high-dose anticoagulants or a common-pathway factor deficiency.
- Low fibrinogen: DIC, massive bleeding, severe liver disease or an inherited fibrinogen disorder.
- Normal profile with bleeding: think of platelet function disorders, von Willebrand disease, vessel wall problems or factor XIII deficiency, none of which may show on routine tests.
When a PT or aPTT is prolonged, a mixing study is a useful next step. The patient’s plasma is mixed with normal plasma; if the time corrects, a factor deficiency is likely, and if it stays prolonged, an inhibitor such as a lupus anticoagulant or factor antibody is suspected. Specific factor assays then pinpoint the problem.
Limitations and Common Pitfalls
A coagulation profile is only as good as the sample. An underfilled tube changes the ratio of blood to citrate anticoagulant and can falsely prolong results. Sampling from a line that contains heparin is a classic cause of an unexpectedly long aPTT.
Normal results do not exclude every problem. Routine tests do not assess platelet function, mild von Willebrand disease or a tendency to clot, so a normal profile does not rule out a clotting disorder such as an inherited thrombophilia. Those require separate, targeted tests.
Finally, a mildly prolonged result in someone with no bleeding history is often of little significance, while a normal result in someone with a convincing bleeding history still deserves further investigation.
Treatment Guided by the Results
Management always targets the underlying cause rather than the number. Vitamin K reverses warfarin effect and nutritional deficiency. Hemophilia is treated with factor replacement or other specialist therapies. Bleeding in liver disease or DIC may call for plasma, cryoprecipitate (a concentrated source of fibrinogen) or platelets, together with treatment of the triggering illness. Tranexamic acid, which slows clot breakdown, helps in many bleeding situations.
For thrombosis, heparin, warfarin and direct oral anticoagulants are the mainstays, and the profile helps balance protection against clots with the risk of bleeding.
When to See a Doctor
Ask your doctor about testing if you notice bruises you cannot explain, nosebleeds lasting more than 10 minutes, very heavy periods, prolonged bleeding after dental work or surgery, or a family history of a bleeding disorder. Seek urgent care for blood in urine or stool, vomiting blood, a sudden severe headache, or one-sided leg swelling with pain or sudden breathlessness, which may signal a clot.
Frequently Asked Questions
Do I need to fast before a coagulation profile?
Fasting is not usually required for PT, aPTT or fibrinogen. Tell the person taking your blood about any blood thinners, supplements or recent heparin, because these directly affect the results.
What is the difference between PT and INR?
The PT is the raw clotting time in seconds, which varies with the reagent each laboratory uses. The INR converts it into a standardized ratio so results can be compared between labs, which is why it is used to adjust warfarin doses.
Can a coagulation profile detect a tendency to form clots?
Not reliably. The routine profile is designed to pick up bleeding tendencies and anticoagulant effects. Thrombophilia screening, when it is appropriate, uses different tests such as protein C, protein S, antithrombin and specific genetic tests.
Why would my aPTT be prolonged if I do not bleed?
Causes that do not lead to bleeding include factor XII deficiency, a sample issue such as heparin contamination, and a lupus anticoagulant, which paradoxically is linked to clotting rather than bleeding. Your doctor will usually repeat the test and, if needed, arrange a mixing study.
